The efficacy and safety of darbepoetin alfa for treating anemia in low-risk myelodysplastic syndrome patients: Results after 53/55 weeks.

被引：0

作者：

Gabrilove, Janice

Paquette, Ronald

Lyons, Roger M.

Mushtaq, Chaudhry

Sekeres, Mikkael A.

Lam, Hung

Dreiling, Lyndah

机构：

[1] Mt Sinai Sch Med, Dept Med, New York, NY USA

[2] Univ Calif Los Angeles, Ctr Oncol, Los Angeles, CA USA

[3] Canc Care Ctr S Texas, US Oncol Res, San Antonio, TX USA

[4] S Carolina Oncol Associates, Columbia, SC USA

[5] Taussig Canc Ctr, Cleveland Clin, Cleveland, OH 44106 USA

[6] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

关键词：

D O I：

10.1182/blood.V108.11.2671.2671

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2671

引用

页码：755A / 755A

页数：1